This research marks a pioneering endeavor in demonstrating SHI's capability to engage Nrf2 activation, contributing to its defensive stance against silica-triggered pulmonary fibrosis and oxidative stress within the lungs, both in vitro and in vivo settings. Here, NFE2L2 is linked to pulmonary fibrosis.